On Thursday, I told you about a major catalyst taking shape in your battery trade. This morning, shares are up 20%. But is it still time to buy into this play?
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
I’m excited to add a new potential biotech catalyst to our portfolio this week! This tiny biotech stock just uplisted onto the Nasdaq eight days ago — and I think that it’s set to get more mainstream attention from Wall Street. Before it does, I want to put it on your radar.
It’s been quite a week. On Monday we got a very big curveball that changed everything… Today, we’ll sell our election havoc hedge and pivot into a COVID-19 vaccine play with a major catalyst coming up this month.
Shares of our most recent buy are skyrocketing this morning. But now’s not the time to chase… We have further guidance on the stock action for you. Plus, be on the lookout for another update later today.
Today there is a big catalyst play I would like to share. It is a biotech that has an important catalyst date coming up at the end of next month. Now is the time to get in....
We’re adding a brand-new catalyst to the portfolio today – and it could be out of this world… Space offers some incredible opportunities, not only for services beamed down to Earth from satellites, but also from incredible new businesses on the horizon like space mining.
Reports are hitting this month that China is looking into cutting supplies of rare earth metals in a move to hurt American defense firms. This is a major catalyst to look for in the year ahead. And today’s play offers us exposure to a sector that can only benefit from it.